Isolation ofClostridium difficilefrom the Feces and the Antibody in Sera of Young and Elderly Adults-Reference-Cited by-同舟云学术

Isolation ofClostridium difficilefrom the Feces and the Antibody in Sera of Young and Elderly Adults

Published:1981-04 Issue:4 Volume:25 Page:345-351
ISSN:0385-5600
Container-title:Microbiology and Immunology
language:en
Short-container-title:Microbiology and Immunology

Author:

Nakamura Shinichi¹,Mikawa Masato¹,Nakashio Satoshi¹,Takabatake Manabu¹,Okado Imiko¹,Yamakawa Kiyotaka¹,Serikawa Toshihiko¹,Okumura Seiichi¹,Nishida Shoki¹

Affiliation:

1. Department of Bacteriology, School of Medicine; Kanazawa University; Kanazawa Ishikawa 920

Publisher

Wiley

Subject

Virology,Immunology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1348-0421.1981.tb00036.x/fullpdf

Reference21 articles.

1. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia;Bartlett;New Engl. J. Med,1978

2. Pseudomembranous enterocolitis (antibiotic-related colitis);Bartlett;Adv. Intern. Med,1977

3. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis;Bartldett;Gastroenterology,1978

4. Cytotoxicity assay in antibiotic-associated colitis;Chang;J. Infect. Dis,1979

5. Selective and differential medium for isolation of Clostridium difficile;George;J. Clin. Microbiol,1979

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human gut microbiota interactions shape the long-term growth dynamics and evolutionary adaptations ofClostridioides difficile;2024-07-17

2. Understanding host immune responses in Clostridioides difficile infection: Implications for pathogenesis and immunotherapy;iMeta;2024-05-11

3. Unveiling the threat: Characterization ofClostridioides difficileInfection in the Northwest Region of Buenos Aires between 2019-2023 and Associated Risk Factors redefined through a Meta-Analysis;2024-04-26

4. Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile;Pharmaceutics;2022-05-19

5. Immune response against Clostridioides difficile and translation to therapy;Therapeutic Advances in Gastroenterology;2021-01